FDA Inspection
Gland Pharma LimitedGland Pharma Limited – FDA Inspection, Nov 1, 2019
Record Details
This FDA Inspection record concerns Gland Pharma Limited, with an inspection on November 1, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Gland Pharma Limited
- Inspection Date
- November 1, 2019
- Product Type
- Drugs
View Company Profile
ID · dcb210ce-c362-4c32-9e94-f2665152f61b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1110628
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Gland Pharma Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 28, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 18, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 30, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gland Pharma Limited
- FDA Inspection 1220251 - 2023-07-28
- FDA Inspection 1061075 - 2018-06-15
- FDA Inspection 1056489 - 2018-05-18
- FDA Inspection 1010051 - 2017-03-31
- FDA Inspection 936901 - 2015-06-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.